Skip to content
GenoLensGenoLens

LTBP4

Chr 19q13.2

latent transforming growth factor beta binding protein 4

Aliases:
LTBP-4, LTBP-4L, FLJ46318, FLJ90018
MANE:
ENST00000396819.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Ehlers Danlos syndrome with a likely monogenic cause

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Familial pulmonary fibrosis

  • Pneumothorax - familial

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies

    0.74
  • Duchenne muscular dystrophy

    0.42
  • aortic aneurysm

    0.41
  • smoking initiation

    0.35
  • abdominal aortic aneurysm

    0.33
  • mathematical ability

    0.32
  • thoracic aortic aneurysm

    0.30
  • cutis laxa

    0.27
  • Hernia

    0.25
  • Inguinal hernia

    0.24

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Latent-transforming growth factor beta-binding protein 4

Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space. Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.